Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Marzia Locatelli"'
Autor:
Carmen Criscitiello, Giuseppe Curigliano, Stefania Morganti, Gloria Pellizzari, Paolo Tarantino, Carmen Belli, Edoardo Crimini, Matteo Repetto, Angela Esposito, Marzia Locatelli, Ida Minchella, Eleonora Nicolo’, Luca Boscolo Bielo, Grazia Castellano, Pier Paolo Maria Berton Giachetti, Gabriele Antonarelli, Liliana Ascione, Carmine Valenza, Beatrice Taurelli Salimbeni
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d2f3c1f2945b4dd3bc96211b63e82c6a
Autor:
Luca Mazzarella, Federica Giugliano, Eleonora Nicolo’, Edoardo Crimini, Jacopo Uliano, Chiara Corti, Paolo d’Amico, Pamela Trillo Aliaga, Carmine Valenza, Matteo Repetto, Gabriele Antonarelli, Liliana Ascione, Grazia Vivanet, Pierpaolo Berton Giachetti, Ida Minchella, Carmen Belli, Angela Esposito, Marzia Locatelli, Carmen Criscitiello, Giuseppe Curigliano
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Cristina Migali, Monica Milano, Dario Trapani, Carmen Criscitiello, Angela Esposito, Marzia Locatelli, Ida Minchella, Giuseppe Curigliano
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 8 (2016)
Is breast cancer (BC) immunogenic? Many data suggest that it is. Many observations demonstrated the prognostic role of tumor-infiltrating lymphocytes (TILs) in triple negative (TN) and human epidermal growth factor receptor 2 (HER-2)-positive BC. TNB
Externí odkaz:
https://doaj.org/article/b63950ae488c4cb184d3e41f210b3f07
Autor:
Carmen Criscitiello, Antonio Marra, Marta Minotti, Massimo Bellomi, Marzia Locatelli, Carmen Belli, Sara Gandini, Giulia Signorelli, Paola Pricolo, Giuseppe Curigliano, Paolo Tarantino
Publikováno v:
European Journal of Cancer. 139:92-98
Baseline tumour burden is a prognostic factor for patients with melanoma and non-small-cell lung cancer treated with immunotherapy. However, no data are available on its role in other solid tumours, nor for treatment with next-generation immunoncolog
Autor:
Grazia Vivanet, Giuseppe Curigliano, José Luis Sandoval, Carmen Criscitiello, Angela Esposito, Paolo Tarantino, Dario Trapani, Marzia Locatelli, Stefania Morganti, Carmen Belli, Edoardo Crimini, Gabriele Antonarelli, Alex Friedlaender, Pamela Trillo Aliaga, Chiara Corti, Ida Minchella
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5829, p 5829 (2021)
Volume 13
Issue 22
Cancers, Vol 13, Iss 5829, p 5829 (2021)
Volume 13
Issue 22
Simple Summary We investigated for the first time the safety profile of COVID-19 vaccines in patients receiving new antineoplastic agents in early-stage clinical trials, including new immuno-regulatory anti-cancer investigational compounds and drug c
Autor:
Paolo Tarantino, Paolo D'Amico, Chiara Corti, Marzia Locatelli, Liliana Ascione, Stefania Morganti, Giuseppe Curigliano, E. Crimini, G. Vivanet, G. Antonarelli, Carmen Belli, Angela Esposito, P. Trillo
Publikováno v:
Annals of Oncology
Background: Early phase clinical trials often represent a therapeutical opportunity for cancer patients (pts). However, high logistic commitment is demanded for participation. Here we explore the COVID-19 related risk during the pandemic for pts enro
Autor:
Paolo D'Amico, Marzia Locatelli, Ida Minchella, Dario Trapani, Luca Mazzarella, Carmen Criscitiello, Giuseppe Curigliano, Bruno Achutti Duso, Giulia Viale, Carmen Belli
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:299-305
Breast cancer (BC) remains the most frequently diagnosed cancer and the most common cause of cancer death among women of all races worldwide. Over 80% of BC cases are hormone receptor (HR)-positive, comprised of luminal A and luminal B per molecular
Autor:
Saverio Minucci, Angela Esposito, Luca Mazzarella, Ida Minchella, Giuseppe Curigliano, Dario Trapani, Carmen Criscitiello, Marzia Locatelli
Publikováno v:
Expert Opinion on Investigational Drugs. 26:965-971
Breast cancer accounts for 29% of malignant tumors. It is an heterogenous disease covering a spectrum of different molecular subtypes. Epigenetic aberrations may affect gene expression through DNA and histone proteins modifications thus promoting tum
Publikováno v:
Breast Care. 12:152-158
Triple-negative breast cancer (TNBC) represents a heterogeneous breast cancer subtype with a poor prognosis. The optimal adjuvant chemotherapy regimen is still unknown. Although numerous large randomized trials have established the benefit of adjuvan
Autor:
Angela Esposito, Matteo Repetto, Dario Trapani, Paolo Tarantino, Marra, Paola Zagami, Emanuela Ferraro, E. Nicolò, Paolo D'Amico, Giuseppe Curigliano, Carmen Criscitiello, Marzia Locatelli, Stefania Morganti, G. Viale
Publikováno v:
Annals of Oncology. 31:S70-S71